Doubly blind: a systematic review of gender in randomised controlled trials

References

• Koskinen S, Martelin T. Why are socioeconomic mortality differences smaller among women than among men?. Soc Sci Med. 1994; 38: 1385–96. [PubMed Abstract].
   Google Scholar
• Krieger N, Smith GD. Bodies count and body counts: social epidemiology and embodying inequality. Epidemiol Rev. 2004; 26: 92–103. [PubMed Abstract].
   Google Scholar
• Phillips SP. Measuring the health effects of gender. J Epidemiol Community Health. 2008; 62: 368–71. [PubMed Abstract].
   Google Scholar
• Connell RW. Gender. 2002; Cambridge: Polity Press.
   Google Scholar
• Ridgeway CL, Correll SJ. Unpacking the gender system: a theoretical perspective on gender beliefs and social relations. Gen Soc. 2004; 18: 510–31.
   Web of Science ®Google Scholar
• Thorslund M, Wastesson JW, Agahi N, Lagergren M, Parker MG. The rise and fall of women's advantage: a comparison of national trends in life expectancy at 65 years. Eur J Ageing. 2013; 10: 271–7. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Courtenay WH. Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Soc Sci Med. 2000; 50: 1385–401. [PubMed Abstract].
   Google Scholar
• Seifarth JE, McGowan CL, Milne KJ. Sex and life expectancy. Gend Med. 2012; 9: 390–401. [PubMed Abstract].
   Google Scholar
• Lorber J, Moore LJ. Gender and the social construction of illness. 2002; New York: AltaMira Press.
   Google Scholar
• Kaufman JS, MacLehose RF. Which of these is not like the others?. Cancer. 2013; 119: 4216–22. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Maas AHEM, van der Schouw YT, Regitz-Zagrosek V, Swahn E, Appelman YE, Pasterkamp G, etal. Red alert for women's heart: the urgent need for more research and knowledge on cardiovascular disease in women. Proceedings of the Workshop held in Brussels on Gender Differences in Cardiovascular disease, 29 September 2010. Eur Heart J. 2011; 32: 1362–8. [PubMed Abstract].
   Google Scholar
• Arnetz L, Ekberg NR, Alvarsson M. Sex differences in type 2 diabetes: focus on disease course and outcomes. Diabetes Metab Syndr Obes. 2014; 16: 409–20.
   Google Scholar
• Regitz-Zagrosek V. Sex and gender differences in pharmacology. 2012; Berlin: Springer-Verlag.
   Google Scholar
• Nyberg F, Osika I, Evengård B. “The Laundry Bag Project” – unequal distribution of dermatological healthcare resources for male and female psoriatic patients in Sweden. Int J Dermatol. 2008; 47: 144–9. [PubMed Abstract].
   Google Scholar
• Hamberg K. Gender bias in medicine. Women's Health. 2008; 4: 237–43. [PubMed Abstract].
   Google Scholar
• Borkhoff CM, Hawker GA, Kreder HJ, Glazier RH, Mahomed NN, Wright JG. The effect of patients’ sex on physicians’ recommendations for total knee arthroplasty. CMAJ. 2008; 178: 681–7. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Kreatsoulas C, Anand S. Considering race/ethnicity and socio-economic status in randomized controlled trials. A commentary on Frampton et al.'s systematic review generalizing findings and tackling health disparities in asthma research. Soc Sci Med. 2009; 69: 1155–6. [PubMed Abstract].
   Google Scholar
• Phillips SP, Hamberg K. Women's relative immunity to the socio-economic health gradient: artifact or real?. Glob Health Action. 2015; 8 27259, doi: http://dx.doi.org/10.3402/gha.v8.27259.
   Google Scholar
• Swahn E. Stable or not, woman or man: is there a difference?. Eur Heart J. 2012; 33: 2769–70. [PubMed Abstract].
   Google Scholar
• Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, etal. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med. 2013; 369: 920–31. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Anderson DR, Dunbar MJ, Bohm ER, Belzile E, Kahn SR, Zukor D, etal. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med. 2013; 158: 800–6. [PubMed Abstract].
   Google Scholar
• Boyd MA, Kumarasamy N, Moore CL, Nwizu C, Losso MH, Mohapi L, etal. Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study. Lancet. 2013; 381: 2091–9. [PubMed Abstract].
   Google Scholar
• Burmester GR, Blanco R, Charles-Schoeman C, Wollenhaupt J, Zerbini C, Benda B, etal. Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial. Lancet. 2013; 381: 451–60. [PubMed Abstract].
   Google Scholar
• Byrd JC, Furman RR, Coutre SE, Flinn IW, Burger JA, Blum KA, etal. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med. 2013; 369: 32–42. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Culliford LA, etal. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet. 2013; 382: 1258–67. [PubMed Abstract].
   Google Scholar
• Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, etal. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014; 370: 13–22. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Cotton MF, Violari A, Otwombe K, Panchia R, Dobbels E, Rabie H, etal. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013; 382: 1555–63. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Dennis M, Sandercock P, Reid J, Graham C, Forbes J, Murray G. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet. 2013; 382: 516–24. [PubMed Abstract].
   Google Scholar
• Devanand DP, Mintzer J, Schultz SK, Andrews HF, Sultzer DL, de la Pena D, etal. Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med. 2012; 367: 1497–507. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, etal. A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med. 2013; 369: 341–50. [PubMed Abstract].
   Google Scholar
• Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, etal. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med. 2011; 365: 1886–95. [PubMed Abstract].
   Google Scholar
• Douillard JY, Oliner KS, Siena S, Tabernero J, Burkes R, Barugel M, etal. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med. 2013; 369: 1023–34. [PubMed Abstract].
   Google Scholar
• Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, etal. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013; 369: 1206–14. [PubMed Abstract].
   Google Scholar
• Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, etal. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013; 368: 1279–90. [PubMed Abstract].
   Google Scholar
• Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, etal. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet. 2011; 378: 1547–59. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Fleshner NE, Lucia MS, Egerdie B, Aaron L, Eure G, Nandy I, etal. Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial. Lancet. 2012; 379: 1103–11. [PubMed Abstract].
   Google Scholar
• Forster A, Dickerson J, Young J, Patel A, Kalra L, Nixon J, etal. A structured training programme for caregivers of inpatients after stroke (TRACS): a cluster randomised controlled trial and cost-effectiveness analysis. Lancet. 2013; 382: 2069–76. [PubMed Abstract].
   Google Scholar
• Gebre T, Ayele B, Zerihun M, Genet A, Stoller NE, Zhou Z, etal. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial. Lancet. 2012; 379: 143–51. [PubMed Abstract].
   Google Scholar
• Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, Rutten GE, Sandbæk A, etal. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet. 2011; 378: 156–67. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Hoffmann U, Truong QA, Schoenfeld DA, Chou ET, Woodard PK, Nagurney JT, etal. Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med. 2012; 367: 299–308. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Horton MR, Santopietro V, Mathew L, Horton KM, Polito AJ, Liu MC, etal. Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial. Ann Intern Med. 2012; 157: 398–406. [PubMed Abstract].
   Google Scholar
• Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, etal. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012; 366: 2466–73. [PubMed Abstract].
   Google Scholar
• Karim SSA, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, etal. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011; 365: 1492–501.
   PubMed Web of Science ®Google Scholar
• Katz JN, Brophy RH, Chaisson CE, de Chaves L, Cole BJ, Dahm DL, etal. Surgery versus physical therapy for a meniscal tear and osteoarthritis. N Engl J Med. 2013; 368: 1675–84. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Kølle SF, Fischer-Nielsen A, Mathiasen AB, Elberg JJ, Oliveri RS, Glovinski PV, etal. Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial. Lancet. 2013; 382: 1113–20.
   PubMed Web of Science ®Google Scholar
• Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012; 366: 1010–19. [PubMed Abstract].
   Google Scholar
• Lewycka S, Mwansambo C, Rosato M, Kazembe P, Phiri T, Mganga A, etal. Effect of women's groups and volunteer peer counselling on rates of mortality, morbidity, and health behaviours in mothers and children in rural Malawi (MaiMwana): a factorial, cluster-randomised controlled trial. Lancet. 2013; 381: 1721–35. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Liem S, Schuit E, Hegeman M, Bais J, de Boer K, Bloemenkamp K, etal. Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial. Lancet. 2013; 382: 1341–9. [PubMed Abstract].
   Google Scholar
• Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, etal. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013; 369: 111–21. [PubMed Abstract].
   Google Scholar
• Mallick U, Harmer C, Yap B, Wadsley J, Clarke S, Moss L, etal. Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. N Engl J Med. 2012; 366: 1674–85. [PubMed Abstract].
   Google Scholar
• Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, etal. Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med. 2013; 368: 22–33. [PubMed Abstract].
   Google Scholar
• Mateos MV, Hernández MT, Giraldo P, de la Rubia J, de Arriba F, López Corral L, etal. Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma. N Engl J Med. 2013; 369: 438–47. [PubMed Abstract].
   Google Scholar
• Milstone AM, Elward A, Song X, Zerr DM, Orscheln R, Speck K, etal. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet. 2013; 38: 1099–106.
   Google Scholar
• Montalescot G, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay JF, etal. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med. 2013; 369: 999–1010. [PubMed Abstract].
   Google Scholar
• Motzer RJ, Hutson TE, Cella D, Reeves J, Hawkins R, Guo J, etal. Pazopanib versus sunitinib in metastatic renal-cell carcinoma. N Engl J Med. 2013; 369: 722–31. [PubMed Abstract].
   Google Scholar
• Nguyen-Khac E, Thevenot T, Piquet MA, Benferhat S, Goria O, Chatelain D, etal. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med. 2011; 365: 1781–9. [PubMed Abstract].
   Google Scholar
• O'Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, etal. Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med. 2013; 369: 307–18. [PubMed Abstract].
   Google Scholar
• Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, etal. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013; 369: 213–23. [PubMed Abstract].
   Google Scholar
• Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, etal. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet. 2012; 380: 1927–35. [PubMed Abstract].
   Google Scholar
• Pirmohamed M, Burnside G, Eriksson N, Jorgensen AL, Toh CH, Nicholson T, etal. A randomized trial of genotype-guided dosing of warfarin. N Engl J Med. 2013; 369: 2294–303. [PubMed Abstract].
   Google Scholar
• Roberts JD, Wells GA, Le May MR, Labinaz M, Glover C, Froeschl M, etal. Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial. Lancet. 2012; 379: 1705–11. [PubMed Abstract].
   Google Scholar
• Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, etal. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med. 2012; 367: 1297–309. [PubMed Abstract].
   Google Scholar
• Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, etal. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013; 369: 1106–14. [PubMed Abstract].
   Google Scholar
• Sihvonen R, Paavola M, Malmivaara A, Itälä A, Joukainen A, Nurmi H, etal. Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear. N Engl J Med. 2013; 369: 2515–24. [PubMed Abstract].
   Google Scholar
• Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, etal. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012; 366: 591–600. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Soofi S, Cousens S, Iqbal SP, Akhund T, Khan J, Ahmed I, etal. Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomized trial. Lancet. 2013; 382: 29–40. [PubMed Abstract].
   Google Scholar
• Thiele H, Wöhrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B, etal. Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial. Lancet. 2012; 379: 923–31. [PubMed Abstract].
   Google Scholar
• Tylleskär T, Jackson D, Meda N, Engebretsen IM, Chopra M, Diallo AH, etal. Exclusive breastfeeding promotion by peer counsellors in sub-Saharan Africa (PROMISE-EBF): a cluster-randomised trial. Lancet. 2011; 378: 420–7.
   PubMed Web of Science ®Google Scholar
• Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, etal. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013; 369: 1691–703. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, etal. Clopidogrel with Aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013; 369: 11–19. [PubMed Abstract].
   Google Scholar
• Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Gutiérrez F, etal. Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection. N Engl J Med. 2013; 369: 1807–18. [PubMed Abstract].
   Google Scholar
• White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, etal. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med. 2013; 369: 1327–35. [PubMed Abstract].
   Google Scholar
• Wiviott SD, White HD, Ohman EM, Fox KA, Armstrong PW, Prabhakaran D, etal. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet. 2013; 382: 605–13. [PubMed Abstract].
   Google Scholar
• Young SD, Cumberland WG, Lee SJ, Jaganath D, Szekeres G, Coates T. Social networking technologies as an emerging tool for HIV prevention: a cluster randomized trial. Ann Intern Med. 2013; 159: 318–24. [PubMed Abstract].
   Google Scholar
• Zeuzem S, Soriano V, Asselah T, Bronowicki JP, Lohse AW, Müllhaupt B, etal. Faldaprevir and deleobuvir for HCV genotype 1 infection. N Engl J Med. 2013; 369: 630–9. [PubMed Abstract].
   Google Scholar
• Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, etal. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013; 381: 2024–32. [PubMed Abstract].
   Google Scholar
• Hoel AW, Kayssi A, Brahmanandam S, Belkin M, Conte MS, Nguyen LL, etal. Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials. J Vasc Surg. 2009; 50: 349–54. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Furler J, Magin P, Pirotta M, van Driel M. Participant demographics reported in “table 1” of randomized controlled trials: a case of “inverse evidence”?. Int J Equity Health. 2012; 11: 14. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Vidaver RM, Lafleur B, Tong C, Bradshaw R, Marts SA. Women subjects in NIH-funded clinical research literature: lack of progress in both representation and analysis by sex. J Women's Health Gend Based Med. 2000; 9: 495–504.
   PubMedGoogle Scholar
• Geller SE, Koch A, Pellettieri B, Carnes M. Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress?. J Women's Health. 2011; 20: 315–20.
   PubMed Web of Science ®Google Scholar
• Geller SE, Adams MG, Carnes M. Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials. J Women's Health. 2006; 15: 1123–31.
   PubMed Web of Science ®Google Scholar
• Jagsi R, Motomura AR, Amamath S, Jankovic A, Sheets N, Ubel PA. Under-representation of women in high-impact published clinical research. Cancer. 2009; 115: 3293–301. [PubMed Abstract].
   Google Scholar
• Weinberger AH, McKee SA, Mazure CM. Inclusion of women and gender-specific analyses in randomized clinical trials of treatments for depression. J Women's Health. 2010; 19: 1727–32.
   PubMed Web of Science ®Google Scholar
• Johnson SM, Karvonen CA, Phelps CL, Nader S, Sanborn BM. Assessment of analysis by gender in the Cochrane reviews as related to treatment of cardiovascular disease. J Women's Health. 2003; 12: 449–57.
   Web of Science ®Google Scholar
• Yang Y, Carlin AS, Faustino PJ, Motta MI, Hamad ML, He R, etal. Participation of women in clinical trials for new drugs approved by the Food and Drug Administration in 2000–2002. J Women's Health. 2009; 18: 303–310.
   PubMed Web of Science ®Google Scholar
• Ramasubbu K, Gurm H, Litaker D. Gender bias in clinical trials: do double standards still apply?. J Women's Health Gend Based Med. 2001; 8: 757–64.
   Google Scholar
• Epstein S. Inclusion. The politics of difference in medical research. 2007; Chicago, IL: The University of Chicago Press.
   Google Scholar
• European Commission. Research & Innovations, SWAFS. Gendered innovations. Sex and gender policies of major granting agencies. Available from: http://ec.europa.eu/research/swafs/gendered-innovations/index_en.cfm?pg=home [cited 19 January 2016]..
   Google Scholar
• Johnston N, Bornefalk-Hermansson A, Schenck-Gustafsson K, Held C, Goodman SG, Yan AT, etal. Do clinical factors explain persistent sex disparities in the use of acute reperfusion therapy in STEMI in Sweden and Canada?. Eur Heart J Acute Cardiovasc Care. 2013; 2: 350–8. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• National Institutes of Health. NIH guidelines on the inclusion of women and minorities as subjects in clinical research. Fed Regist. 1994; 59: 14508–13.
   Google Scholar